InterCure Ltd. (NASDAQ:INCR - Get Free Report)'s stock price fell 0.7% on Wednesday . The stock traded as low as $1.61 and last traded at $1.61. 24,045 shares changed hands during trading, an increase of 31% from the average session volume of 18,333 shares. The stock had previously closed at $1.62.
InterCure Stock Down 0.1 %
The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.15 and a current ratio of 1.78. The firm's fifty day moving average price is $1.64 and its two-hundred day moving average price is $1.71.
Institutional Investors Weigh In On InterCure
Institutional investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC acquired a new stake in InterCure in the 3rd quarter valued at $43,000. Jane Street Group LLC purchased a new stake in InterCure during the third quarter worth about $49,000. Finally, Moore Capital Management LP purchased a new stake in InterCure during the fourth quarter worth about $156,000. Institutional investors and hedge funds own 8.34% of the company's stock.
About InterCure
(
Get Free Report)
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
See Also
Before you consider InterCure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InterCure wasn't on the list.
While InterCure currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
